Pratik Bhagunde

Impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety and tolerability of relebactam combined with imipenem and cilastatin

S. Xu, M. Rizk, Pratik Bhagunde, 2019, British journal of clinical pharmacology.

Population Pharmacokinetic Analysis for Imipenem–Relebactam in Healthy Volunteers and Patients With Bacterial Infections

M. Rizk, Pratik Bhagunde, Mallika Lala, 2019, CPT: pharmacometrics & systems pharmacology.

Thorough QTc Study of a Single Supratherapeutic Dose of Relebactam in Healthy Participants

M. Rizk, Pratik Bhagunde, Francheska M. Colón-González, 2020, Clinical pharmacology in drug development.

A translational pharmacokinetic/pharmacodynamic model to characterize bacterial kill in the presence of imipenem-relebactam.

M. Rizk, Pratik Bhagunde, Jin Wu, 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Exploring the Pharmacokinetic/Pharmacodynamic Relationship of Relebactam (MK-7655) in Combination with Imipenem in a Hollow-Fiber Infection Model

M. Motyl, M. Rizk, Pratik Bhagunde, 2018, Antimicrobial Agents and Chemotherapy.

Modeling Heterogeneous Bacterial Populations Exposed to Antibiotics: The Logistic-Dynamics Case.

M. Nikolaou, V. Tam, Pratik Bhagunde, 2015, AIChE journal. American Institute of Chemical Engineers.

Pharmacokinetics of elbasvir and grazoprevir in subjects with end-stage renal disease or severe renal impairment

Pratik Bhagunde, J. Butterton, D. Panebianco, 2019, European Journal of Clinical Pharmacology.

Discovery of efficacious Pseudomonas aeruginosa-targeted siderophore-conjugated monocarbams by application of a semi-mechanistic pharmacokinetic/pharmacodynamic model.

D. Ehmann, V. Galullo, Pratik Bhagunde, 2015, Journal of medicinal chemistry.

Novel Modeling Framework To Guide Design of Optimal Dosing Strategies for β-Lactamase Inhibitors

M. Nikolaou, V. Tam, Pratik Bhagunde, 2012, Antimicrobial Agents and Chemotherapy.